Paul E. Freiman's Net Worth

$98 Thousand

Estimate Recalculated May 30, 2024 08:32PM EST

Who is Paul E. Freiman?

Paul E. Freiman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NovaBay Pharmaceuticals, Inc., and Neurotrope, Inc..

SEC CIK

Paul E. Freiman's CIK is 0001410074

Past Insider Trading and Trends

2009 was Paul E. Freiman's most active year for acquiring shares with 12 total transactions. Paul E. Freiman's most active month to acquire stocks was the month of December. 2009 was Paul E. Freiman's most active year for disposing of shares, totalling 6 transactions. Paul E. Freiman's most active month to dispose stocks was the month of July. 2011 saw Paul E. Freiman paying a total of $8,520.00 for 48,000 shares, this is the most they've acquired in one year. In 2009 Paul E. Freiman cashed out on 30,886 shares for a total of $58,250.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NovaBay Pharmaceuticals, Inc. (NBY) Snapshot price: $0.1331

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 28
Form 4
0
0
Jun 9
Form 4
+100.00%
858
1.72K
May 11
Form 4
30K
30K
May 21
Form 4
0
0
May 11
Form 4
0
0
May 21
Form 4
0
0
May 26
Form 4
0
0
May 30
Form 4
0
0
May 31
Form 4
0
0
Jan 3
Form 4
0
0
Jan 3
Form 4
0
0
Jan 4
Form 4
0
0
Jan 2
Form 4
0
0
Jan 2
Form 4
0
0
Jan 2
Form 4
+198.19%
30K
$0.20
$6,000.00
45.14K
Dec 29
Form 4
0
0
Jan 3
Form 4
+24.72%
3K
$0.84
$2,520.00
15.14K
Sep 12
Form 4/A
+4.22%
1.35K
33.41K
Aug 25
Form 4
0
0
Jan 3
Form 4/A
+1.28%
343
27.14K
Oct 6
Form 4/A
+5.31%
1.35K
26.79K
Sep 14
Form 4/A
-5.31%
-1.43K
25.44K
Aug 28
Form 4
-55.28%
-15.00K
$1.83
-$27,450.00
12.14K
Aug 16
Form 4
-5.31%
-1.43K
25.44K
Aug 28
Form 4
0
0
Jan 4
Form 4
+1.33%
343
26.14K
Oct 6
Form 4
-4.97%
-1.35K
25.79K
Sep 14
Form 4
-5.52%
-1.43K
24.44K
Aug 28
Form 4
-1.04%
-252.00
24.02K
Aug 13
Form 4
-51.27%
-25.00K
$2.33
-$58,250.00
23.76K
Jun 11
Form 4
+2.89%
1.37K
48.76K
Jun 4
Form 4
+0.49%
231
47.4K
May 14
Form 4
+0.55%
256
47.16K
May 7
Form 4
+0.51%
236
46.91K
Mar 30
Form 4
+2.99%
1.36K
46.67K
Mar 26
Form 4
+0.81%
363
45.31K
Mar 19
Form 4
+4.88%
2.09K
44.95K
Mar 10
Form 4
+0.85%
363
42.86K
Jan 28
Form 4
+27.19%
9.08K
42.5K
Jan 14
Form 4
+4.22%
1.35K
33.41K
Aug 25
Form 4
+3.15%
978
32.06K
Jun 5
Form 4
+2.49%
1.48K
60.95K
Apr 1 - Apr 16
Form 4
+3.55%
1.01K
29.6K
Mar 6
Form 4
+4.28%
1.17K
28.59K
Feb 29
Form 4
+0.75%
205
27.41K
Feb 11
Form 4
+4.46%
1.16K
27.21K
Jan 14
Form 4
+2.75%
698
26.05K
Dec 14
Form 4
+0.94%
236
25.35K
Dec 7 - Dec 11
Form 4
+0.45%
113
25.11K
Nov 5
Form 3
0
0
No matching records found

Neurotrope, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 19
Form 4
0
0
Nov 13
Form 4
0
0
Sep 12
Form 3
0
0
No matching records found